Skip to main content
Erschienen in: Intensivmedizin und Notfallmedizin 6/2011

01.09.2011 | Kasuistik

Successful bridge to recovery using a microaxial blood pump in a patient with electrical storm and cardiogenic shock

verfasst von: Dr. A. Henning, J. Schreieck, R. Riessen, M. Gawaz, A.E. May

Erschienen in: Intensivmedizin und Notfallmedizin | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

A 59-year-old patient with dilated cardiomyopathy and incessant ventricular tachycardia leading to progressive cardiogenic shock is presented. Due to hemodynamic instability, high dose catecholamines were required in addition to the implantation of an intraaortic balloon pump (IABP), which, however, appeared to further augment the frequency and duration of ventricular tachycardias. The implantation of a microaxial blood pump allowed catecholamine administration to be terminated, thereby, ending this vicious circle of catecholamine-driven electrical storm. Within 5 days, the patient was hemodynamically stabilized and kidney and liver function recovered with the support of intensive antiarrhythmic therapy (amiodarone, mexiletine, sotalol). During a 24-month follow-up, the patient had no further ICD shocks and no rehospitalization was required for treatment of congestive heart failure.
Literatur
1.
Zurück zum Zitat Siegenthaler MP, Brehm K, Strecker T et al (2004) The Impella recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg 127:812PubMedCrossRef Siegenthaler MP, Brehm K, Strecker T et al (2004) The Impella recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg 127:812PubMedCrossRef
2.
Zurück zum Zitat Jurmann MJ, Siniawski H, Erb M et al (2004) Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 77:1642PubMedCrossRef Jurmann MJ, Siniawski H, Erb M et al (2004) Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 77:1642PubMedCrossRef
3.
Zurück zum Zitat Colombo T, Garatti A, Vitali E et al (2003) First successful bridge to recovery with the Impella recover 100 left ventricular assist device for fulminant acute myocarditis. Ital Heart J 4(9):642–645PubMed Colombo T, Garatti A, Vitali E et al (2003) First successful bridge to recovery with the Impella recover 100 left ventricular assist device for fulminant acute myocarditis. Ital Heart J 4(9):642–645PubMed
4.
Zurück zum Zitat Thomopoulou S, Manginas A, Cokkinos DV (2008) Initial experience with the Impella recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty. Hellenic J Cardiol 49(6):382–387PubMed Thomopoulou S, Manginas A, Cokkinos DV (2008) Initial experience with the Impella recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty. Hellenic J Cardiol 49(6):382–387PubMed
5.
Zurück zum Zitat Seyfarth M, Sibbing D, Schömig A et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584–1588PubMedCrossRef Seyfarth M, Sibbing D, Schömig A et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584–1588PubMedCrossRef
6.
Zurück zum Zitat Dixon SR, Henriques JP, O’Neill WW et al (2009) A prospective feasibility trial investigating the use of the impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2(2):91–96PubMedCrossRef Dixon SR, Henriques JP, O’Neill WW et al (2009) A prospective feasibility trial investigating the use of the impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2(2):91–96PubMedCrossRef
7.
Zurück zum Zitat Mueller XM, Boone Y, Segesser LK von et al (2001) Biventricular axial micropump: impact on blood cell integrity. Swiss Surg 7(5):213–217PubMedCrossRef Mueller XM, Boone Y, Segesser LK von et al (2001) Biventricular axial micropump: impact on blood cell integrity. Swiss Surg 7(5):213–217PubMedCrossRef
8.
Zurück zum Zitat Fishberger SB, Asnes JD, Cleman MW et al (2010) Percutaneous right ventricular support during catheter ablation of intra-atrial reentrant tachycardia in an adult with a mustard baffle. A novel use of the Impella device. J Interv Card Electrophysiol 29(1):69–72PubMedCrossRef Fishberger SB, Asnes JD, Cleman MW et al (2010) Percutaneous right ventricular support during catheter ablation of intra-atrial reentrant tachycardia in an adult with a mustard baffle. A novel use of the Impella device. J Interv Card Electrophysiol 29(1):69–72PubMedCrossRef
9.
Zurück zum Zitat Abuissa H, Roshan J, Asirvatham SJ et al (2010) Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia. J Cardiovasc Electrophysiol 21(4):458–461PubMedCrossRef Abuissa H, Roshan J, Asirvatham SJ et al (2010) Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia. J Cardiovasc Electrophysiol 21(4):458–461PubMedCrossRef
10.
Zurück zum Zitat Remmelink M, Sjauw KD, Henriques JP et al (2007) Effects of left ventricular unloading by impella recover LP 2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 70(4):532–537PubMedCrossRef Remmelink M, Sjauw KD, Henriques JP et al (2007) Effects of left ventricular unloading by impella recover LP 2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 70(4):532–537PubMedCrossRef
11.
Zurück zum Zitat Henriques JPS, Remmelink M, Baan J et al (2006) Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella recover LP 2.5. Am J Cardiol 97(7):990–992PubMedCrossRef Henriques JPS, Remmelink M, Baan J et al (2006) Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella recover LP 2.5. Am J Cardiol 97(7):990–992PubMedCrossRef
12.
Zurück zum Zitat Dixon SR, Henriques JPS, Mauri L et al (2009) A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial): initial U.S. experience. J Am Coll Cardiol 2:91–96 Dixon SR, Henriques JPS, Mauri L et al (2009) A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial): initial U.S. experience. J Am Coll Cardiol 2:91–96
13.
Zurück zum Zitat Engström A, Sjauw K, Henriques J et al (2011) Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction. EuroIntervention 6(7):860–865PubMedCrossRef Engström A, Sjauw K, Henriques J et al (2011) Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction. EuroIntervention 6(7):860–865PubMedCrossRef
Metadaten
Titel
Successful bridge to recovery using a microaxial blood pump in a patient with electrical storm and cardiogenic shock
verfasst von
Dr. A. Henning
J. Schreieck
R. Riessen
M. Gawaz
A.E. May
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Intensivmedizin und Notfallmedizin / Ausgabe 6/2011
Print ISSN: 0175-3851
Elektronische ISSN: 1435-1420
DOI
https://doi.org/10.1007/s00390-011-0289-3

Weitere Artikel der Ausgabe 6/2011

Intensivmedizin und Notfallmedizin 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.